2020
DOI: 10.1016/j.scp.2020.100300
|View full text |Cite
|
Sign up to set email alerts
|

Immuno biocompatibility and anti-quorum sensing activities of chitosan-gum acacia gold nanocomposite (CS-GA-AuNC) against Pseudomonas aeruginosa drug-resistant pathogen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…4 With its biocompatibility, biodegradability, and adsorption properties, chitosan serves as an integral component in composite materials, contributing to the acquisition of unique characteristics through diverse combinations. [5][6][7][8] Furthermore, CS has demonstrated antimicrobial and anti-biolm properties. In the case of G-bacteria, these effects are attributed to the chelation of bivalent ions (Ca 2+ and Mg 2+ ) from the bacterial outer membrane and electrostatic interactions with the anionic components of lipopolysaccharides.…”
Section: Introductionmentioning
confidence: 99%
“…4 With its biocompatibility, biodegradability, and adsorption properties, chitosan serves as an integral component in composite materials, contributing to the acquisition of unique characteristics through diverse combinations. [5][6][7][8] Furthermore, CS has demonstrated antimicrobial and anti-biolm properties. In the case of G-bacteria, these effects are attributed to the chelation of bivalent ions (Ca 2+ and Mg 2+ ) from the bacterial outer membrane and electrostatic interactions with the anionic components of lipopolysaccharides.…”
Section: Introductionmentioning
confidence: 99%
“…With this objective, the current study is undertaken to evaluate the molecular mechanism inhibition of virulence genes produced by Pseudomonas aeruginosa. P. aeruginosa major Gram-negative, aero bacilli are known to cause a wide range of severe infections with an elevated rate of mortality and morbidity [32] P. aeruginosa infection is often refractory to antibiotic therapy due to multidrug resistance, making it a World Health Organization and U.S. Centers for Disease Control priority pathogen for therapeutic development [33]. P. aeruginosa produces various virulence factors in a coordinated system that enables host colonisation and adaptation [34][35][36].…”
Section: Introductionmentioning
confidence: 99%